loadpatents
Patent applications and USPTO patent grants for Zeevaart; Jan Rijn.The latest application filed is for "production of radioisotopes".
Patent | Date |
---|---|
Radiopharmaceutical conjugate of a metabolite and an EPR agent, for targeting tumour cells Grant 10,874,753 - Driver , et al. December 29, 2 | 2020-12-29 |
Production of Radioisotopes App 20200312476 - Zeevaart; Jan Rijn | 2020-10-01 |
Pharmaceutical composition Grant 10,363,324 - Grobler , et al. | 2019-07-30 |
Radiopharmaceutical Conjugate App 20170296684 - DRIVER; Cathryn Helena Stanford ;   et al. | 2017-10-19 |
A Kit For Preparing A Radiopharmaceutical App 20160346412 - Zeevaart; Jan Rijn ;   et al. | 2016-12-01 |
Pharmaceutical Composition App 20160271279 - Grobler; Anne Frederica ;   et al. | 2016-09-22 |
Method of producing radionuclides Grant 9,047,998 - Jansen , et al. June 2, 2 | 2015-06-02 |
Anticancer Agent App 20140199240 - Zeevaart; Jan Rijn ;   et al. | 2014-07-17 |
Method Of Producing Radionuclides App 20130170593 - Jansen; David Randall ;   et al. | 2013-07-04 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.